K C Kain
Overview
Explore the profile of K C Kain including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
1768
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boggild A, Geduld J, Libman M, Yansouni C, McCarthy A, Hajek J, et al.
Can Commun Dis Rep
. 2018 May;
42(8):153-157.
PMID: 29770022
Background: In light of the 2016 summer Olympic games it is anticipated that Canadian practitioners will require information about common illnesses that may affect travellers returning from Brazil. Objective: To...
2.
Boggild A, Geduld J, Libman M, Ward B, McCarthy A, Hajek J, et al.
Can Commun Dis Rep
. 2018 May;
40(16):313-325.
PMID: 29769859
Background: Important gaps remain in our knowledge of the infectious diseases people acquire while travelling and the impact of pathogens imported by Canadian travellers. Objective: To provide a surveillance update...
3.
Turnbull H, Conroy A, Opoka R, Namasopo S, Kain K, Hawkes M
Int J Tuberc Lung Dis
. 2016 Apr;
20(5):696-703.
PMID: 27084827
Setting: A resource-limited paediatric hospital in Uganda. Objective: Pneumonia is a leading cause of child mortality worldwide. Access to life-saving oxygen therapy is limited in many areas. We designed and...
4.
Kain K
J Travel Med
. 2013 Apr;
6 Suppl 1:S2-7.
PMID: 23573545
There are currently a limited number of drugs available to prevent malaria in travelers, and new, more efficacious, and better tolerated regimens are urgently needed. Clearly, none of the available...
5.
Kain K
Can J Infect Dis
. 2012 Apr;
7(1):25-33.
PMID: 22514413
Objective: To review the impact of drug-resistant malaria on current management of plasmodial infections. Data Sources: A MEDLINE search of the English-language medical literature from 1985 to 1995; bibliographies of...
6.
Baqi M, Gamble K, Keystone J, Kain K
Can J Infect Dis
. 2012 Feb;
9(3):183-4.
PMID: 22346541
Although local acquisition of malaria has been reported in the United States, no such cases have been reported in Canada. The authors report a case of Plasmodium vivax malaria in...
7.
Berghout J, Higgins S, Loucoubar C, Sakuntabhai A, Kain K, Gros P
Genes Immun
. 2011 Aug;
13(1):98-102.
PMID: 21833022
Previously, we have shown that pyruvate kinase, liver and red cell isoform (PKLR) deficiency protects mice in vivo against blood-stage malaria, and observed that reduced PKLR function protects human erythrocytes...
8.
Rajgor D, Gogtay N, Kadam V, Kamtekar K, Dalvi S, Chogle A, et al.
Trans R Soc Trop Med Hyg
. 2004 Jul;
97(4):438-40.
PMID: 15259476
We studied the antirelapse efficacy of a supervised 14-d 15 mg/d regimen of primaquine therapy (n = 131) compared with no antirelapse therapy (n = 142) in 273 patients with...
9.
Pillai D, Kobayashi S, Kain K
Exp Parasitol
. 2002 Mar;
99(4):226-34.
PMID: 11888250
Amebiasis contributes to approximately 50 million cases of life-threatening dysentery worldwide. Comparison of the lectins from Entamoeba histolytica (pathogenic) and Entamoeba dispar (nonpathogenic) was undertaken to elucidate the differential roles...
10.
Labbe A, Bualombai P, Pillai D, Zhong K, Vanisaveth V, Hongvanthong B, et al.
Ann Trop Med Parasitol
. 2002 Jan;
95(8):781-8.
PMID: 11784432
Chloroquine-resistant Plasmodium falciparum is well documented in Thailand. Laos, however, continues to use chloroquine (CQ) as the first-line therapy for the treatment of P. falciparum malaria. The objective of the...